Does tesamorelin help build muscle?

Lean body mass isn't the same thing as muscle

Lean body mass is everything in the body that isn’t fat: muscle, and also bone, organs and water. A rise in it tells you the fat-free part of a person got heavier, not which part.

Water is the part worth watching here. The label lists fluid retention among the drug’s effects, with swelling and joint pain, and gives its own explanation: “Fluid retention may occur during EGRIFTA SV therapy and is thought to be related to the induction of GH secretion.”¹ The label reports the lean-mass gain as one number. It doesn’t say how much of it was muscle. Its other warnings are laid out on is tesamorelin safe.

The direction has held since the first dose-finding trial, 61 patients given 1 mg, 2 mg or placebo for 12 weeks, which reported it plainly:²

The one study that measured muscle directly

One group went back to the CT scans from two completed trials in people with HIV and looked at the muscle itself: four trunk muscle groups at the lower back, measured for area and for density, which the study reads as muscle quality.³

Against placebo, all four groups got denser, by 1.56 to 4.86 Hounsfield units, and the lean area of all four grew by 0.64 to 1.08 square centimeters. Total area rose in two of them, the rectus and the psoas, by 0.44 and 0.46 square centimeters.³ That’s real change, and it’s small: the largest gain in any muscle group is about one square centimeter of cross-section.

The paper states its own two limits. It calls itself a secondary, exploratory analysis, done after the trials were over, and it counted only the people whose belly fat had already responded: “Tesamorelin participants were restricted to responders (visceral adipose tissue decrease ≥8%).”³

They end on what they didn’t measure: “the impact of these changes in daily life should be further studied”.

What happens when the injections stop

The gain lasted as long as the injections did. At week 26 the trials split the people who had been on the drug: some stayed on it and some were switched, without knowing it, to placebo. The ones kept on it held their lean mass. The ones switched lost 1.8 kg and 1.7 kg over the following 26 weeks, and their visceral fat climbed back by 22% and 16%.¹

Whatever it adds, it adds while you’re taking it.

In healthy people, and the trial that will test function

Two trials that enrolled healthy people report no muscle result in their abstracts. One gave 13 healthy men 2 mg of tesamorelin a day for 2 weeks and measured their hormones: overnight growth hormone went up, and IGF-I rose by 181 µg/liter.⁴ The other was a memory trial, 1 mg a day for 20 weeks in 152 adults aged 55 to 87, some healthy and some with mild cognitive impairment. Its abstract says the drug “reduced percent body fat by 7.4%” and gives no figure for lean mass.⁵

The trial built to ask a version of the muscle question is TRIUMPH. Its protocol, published in July 2026, plans to randomize 100 sedentary adults aged 50 to 80 with HIV, all frail or close to it and all carrying excess belly fat, to the drug or placebo alongside a home-based exercise program for 24 weeks, then 24 more of exercise on their own. It will measure physical function, muscle content and quality at weeks 24 and 48.⁶ There are no results yet.

Where the muscle idea comes from

From the mechanism, mostly. Tesamorelin makes the pituitary release growth hormone through the GHRH receptor, one of two routes to that hormone, and the label describes growth hormone as both anabolic and lipolytic, muscle-building and fat-burning.¹ The trials were built around the second word: visceral fat was the primary endpoint, and lean mass was one of several others. What the drug is, and the one use it’s approved for, is on what is tesamorelin.

A 2026 review written for doctors whose patients self-inject these peptides was blunt about the fitness claims:

The same review collects what people report doing online, in a table it labels “anthropological/behavioural data, not clinical recommendations”. For this drug the entry reads “Bodybuilding-related forum: 2 mg SC once daily; typical cycle: 8–12 weeks”.⁷ Set that beside the trials: the lean-mass figures above were read at week 26, more than twice the length of the longest cycle in that entry. Forum cycles stand in for trial timelines across these peptides, and the same gap is laid out for CJC-1295 and ipamorelin.

Some sellers pair the drug with ipamorelin, a different route to the same hormone; that pairing is taken apart on tesamorelin vs ipamorelin, every figure the sellers here publish is on the board on the home page, and each seller’s page as read is under seller records.

Sources